GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » EPS without NRI

CLS Holdings USA (XCNQ:CLSH) EPS without NRI : C$-0.09 (TTM As of Feb. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA EPS without NRI?

CLS Holdings USA's earnings per share without non-recurring items for the three months ended in Feb. 2024 was C$-0.03. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.09.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 11.30% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 39.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for CLS Holdings USA's EPS without NRI or its related term are showing as below:

XCNQ:CLSH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -26.6   Med: 19.3   Max: 59.3
Current: 11.3

During the past 11 years, CLS Holdings USA's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 59.30% per year. The lowest was -26.60% per year. And the median was 19.30% per year.

XCNQ:CLSH's 3-Year EPS without NRI Growth Rate is ranked better than
50.6% of 838 companies
in the Drug Manufacturers industry
Industry Median: 10.95 vs XCNQ:CLSH: 11.30

CLS Holdings USA's EPS (Diluted) for the three months ended in Feb. 2024 was C$-0.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.15.

CLS Holdings USA's EPS (Basic) for the three months ended in Feb. 2024 was C$-0.05. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.15.


CLS Holdings USA EPS without NRI Historical Data

The historical data trend for CLS Holdings USA's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA EPS without NRI Chart

CLS Holdings USA Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.45 -0.23 -0.39 -0.09 -0.15

CLS Holdings USA Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 -0.01 -0.03 -0.03

Competitive Comparison of CLS Holdings USA's EPS without NRI

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's PE Ratio without NRI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's PE Ratio without NRI falls into.



CLS Holdings USA EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CLS Holdings USA  (XCNQ:CLSH) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


CLS Holdings USA EPS without NRI Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (XCNQ:CLSH) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.